Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-01-28 @ 8:32 PM
Study NCT ID:
NCT00232505
Status:
COMPLETED
Last Update Posted:
2017-06-28
First Post:
2005-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11
Start Date Type:
ACTUAL
Primary Completion Date:
2010-06-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-03
First Submit QC Date:
None
Study First Post Date:
2005-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-07
Results First Submit QC Date:
None
Results First Post Date:
2017-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-25
Last Update Post Date:
2017-06-28
Last Update Post Date Type:
ACTUAL